| P50 | author | Florence Ader | Q63777339 |
| | Saad Nseir | Q63968880 |
| | Anne-Lise Bienvenu | Q91940783 |
| | Blandine Rammaert | Q39381962 |
| P2860 | cites work | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease | Q22299313 |
| | CT signs and patterns of lung disease | Q28204293 |
| | Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis | Q28217179 |
| | Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease | Q28251330 |
| | Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America | Q28263689 |
| | Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans | Q28265703 |
| | Invasive aspergillosis in the intensive care unit | Q28306909 |
| | Aspergillosis case-fatality rate: systematic review of the literature | Q31918085 |
| | Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells | Q33361111 |
| | Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR. | Q33964096 |
| | Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis | Q33980836 |
| | Newer systemic antifungal agents : pharmacokinetics, safety and efficacy | Q33981062 |
| | Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group | Q34002098 |
| | Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review | Q34230722 |
| | Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis | Q34514484 |
| | Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon | Q34563875 |
| | Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis | Q35219726 |
| | Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis | Q35636789 |
| | Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients | Q35913870 |
| | Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients | Q35923365 |
| | CT halo sign: the spectrum of pulmonary diseases | Q36234620 |
| | Invasive Pulmonary Aspergillosis in Patients with Chronic Obstructive Pulmonary Disease: Report of Eight Cases and Review | Q57238104 |
| | Galactomannan in Bronchoalveolar Lavage Fluid | Q57559940 |
| | Invasive aspergillosis in immunocompromised patients: findings on plain film and (HR)CT | Q57891159 |
| | Prognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease | Q61875242 |
| | Inhibition of monocyte-mediated damage to fungal hyphae by steroid hormones | Q71654513 |
| | The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study | Q72313200 |
| | Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia | Q73336907 |
| | Diagnosis of pulmonary aspergillosis using optical brighteners | Q73520140 |
| | Comparison of premortem clinical diagnoses in critically iII patients and subsequent autopsy findings | Q73892686 |
| | Detection of Aspergillus galactomannan antigen in foods and antibiotics | Q74200091 |
| | Invasive aspergillosis. Clinical features of 35 proven cases at a single institution | Q74754465 |
| | Inhaled corticosteroids in chronic obstructive pulmonary disease and disseminated aspergillosis | Q75445991 |
| | Aspergillus detection in bronchoscopically acquired material. Significance and interpretation | Q77418828 |
| | Polymerase chain reaction on blood for the diagnosis of invasive pulmonary aspergillosis in cancer patients | Q77838929 |
| | Clinical insignificance of (1→3)-β-d-glucan in early diagnosis of invasive pulmonary aspergillosis in a patient with chronic obstructive pulmonary disease | Q79130290 |
| | Invasive aspergillosis in critically ill patients without malignancy | Q80269940 |
| | Aspergillosis in the ICU - The new 21st century problem? | Q92929057 |
| | The radiological spectrum of pulmonary aspergillosis | Q36235123 |
| | Laboratory diagnosis of invasive aspergillosis. | Q36267587 |
| | The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis | Q36278972 |
| | Clinical pharmacokinetics of voriconazole. | Q36431010 |
| | Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR. | Q36521719 |
| | Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality | Q36715387 |
| | Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature | Q37095685 |
| | Update on azole antifungals | Q37118861 |
| | Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ | Q37164067 |
| | Hallucinations during voriconazole therapy | Q37307500 |
| | Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis | Q37380385 |
| | Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid | Q37702655 |
| | Adverse reactions to voriconazole. | Q38918614 |
| | Fulminant invasive pulmonary aspergillosis in immunocompetent patients--a two-case report | Q40543559 |
| | The value of the chest computed tomography halo sign in the diagnosis of invasive pulmonary aspergillosis. An autopsy-based retrospective study of 48 patients | Q40565864 |
| | Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients | Q40621659 |
| | Workload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital. | Q41791143 |
| | The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis | Q41832344 |
| | Anticoagulants interfere with PCR used to diagnose invasive aspergillosis. | Q42833328 |
| | Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients | Q43721640 |
| | Immunoparalysis as a cause for invasive aspergillosis? | Q43798573 |
| | Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of aspergillus in BAL. | Q43955608 |
| | The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis | Q44060978 |
| | Invasive pulmonary filamentous fungal infection in a patient receiving inhaled corticosteroid therapy | Q44098424 |
| | Disseminated aspergillosis in intensive care unit patients: an autopsy study | Q44392075 |
| | Safety of voriconazole and dose individualization | Q44396667 |
| | Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosis | Q44548714 |
| | Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study | Q44662579 |
| | False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. | Q44688423 |
| | False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam. | Q44785839 |
| | How does a patient maximally benefit from anti-infective chemotherapy? | Q45108765 |
| | Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model | Q46148256 |
| | Comparative study on the efficacy of liposomal amphotericin B and voriconazole in a murine pulmonary aspergillosis model | Q46158354 |
| | Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay | Q46503389 |
| | What is the "therapeutic range" for voriconazole? | Q46826184 |
| | Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes | Q46826187 |
| | Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis | Q47561157 |
| | Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. | Q47799923 |
| | Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence | Q47997226 |
| | Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients. | Q51191494 |
| | The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. | Q51191763 |
| | Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. | Q51192216 |
| | Invasive pulmonary aspergillosis: frequency and meaning of the "hypodense sign" on unenhanced CT. | Q53576056 |
| | Invasive pulmonary aspergillosis: prediction at thin-section CT in patients with neutropenia--a prospective study. | Q53946877 |
| | The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. | Q54622007 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic obstructive pulmonary disease | Q199804 |
| | antifungal | Q578726 |
| | triazoles | Q903341 |
| | invasive pulmonary aspergillosis | Q54946623 |
| | pyrimidine | Q109367514 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 279-287 | |
| P577 | publication date | 2009-08-03 | |
| P1433 | published in | International Journal of Chronic Obstructive Pulmonary Disease | Q6051335 |
| P1476 | title | Management of invasive aspergillosis in patients with COPD: rational use of voriconazole | |
| P478 | volume | 4 | |